Cargando…
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
Helicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto global consensus report on H. pylori gastritis recommended H. pylori eradication therapy to prevent gastric cancer. To manage H. pylori infection, it is important to choose the appropriate regimen considering...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847180/ https://www.ncbi.nlm.nih.gov/pubmed/29138921 http://dx.doi.org/10.1007/s00535-017-1407-1 |
_version_ | 1783305703293714432 |
---|---|
author | Suzuki, Hidekazu Mori, Hideki |
author_facet | Suzuki, Hidekazu Mori, Hideki |
author_sort | Suzuki, Hidekazu |
collection | PubMed |
description | Helicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto global consensus report on H. pylori gastritis recommended H. pylori eradication therapy to prevent gastric cancer. To manage H. pylori infection, it is important to choose the appropriate regimen considering regional differences in resistance to clarithromycin and metronidazole. Quinolones and rifabutin-containing regimens are useful as third- and fourth-line rescue therapies. |
format | Online Article Text |
id | pubmed-5847180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-58471802018-03-20 World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat Suzuki, Hidekazu Mori, Hideki J Gastroenterol Review Helicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto global consensus report on H. pylori gastritis recommended H. pylori eradication therapy to prevent gastric cancer. To manage H. pylori infection, it is important to choose the appropriate regimen considering regional differences in resistance to clarithromycin and metronidazole. Quinolones and rifabutin-containing regimens are useful as third- and fourth-line rescue therapies. Springer Japan 2017-11-14 2018 /pmc/articles/PMC5847180/ /pubmed/29138921 http://dx.doi.org/10.1007/s00535-017-1407-1 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Suzuki, Hidekazu Mori, Hideki World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat |
title | World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat |
title_full | World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat |
title_fullStr | World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat |
title_full_unstemmed | World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat |
title_short | World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat |
title_sort | world trends for h. pylori eradication therapy and gastric cancer prevention strategy by h. pylori test-and-treat |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847180/ https://www.ncbi.nlm.nih.gov/pubmed/29138921 http://dx.doi.org/10.1007/s00535-017-1407-1 |
work_keys_str_mv | AT suzukihidekazu worldtrendsforhpylorieradicationtherapyandgastriccancerpreventionstrategybyhpyloritestandtreat AT morihideki worldtrendsforhpylorieradicationtherapyandgastriccancerpreventionstrategybyhpyloritestandtreat |